Conclusions
The global pandemic
from COVID-19 represents one of the greatest health challenges in human
history. Pending the discovery of an effective vaccine and antivirals
directed against Sars-Cov-2, it is essential to recognize factors that
may increase the risk of infection or worsen complications from
COVID-19. The identification of effective preventive and therapeutic
strategies is urgently needed especially for patients with chronic
diseases such as diabetes. Patients with diabetes are at greater risk in
this pandemic period, and even diabetes therapy can be complex to manage
during a COVID-19 infection. Clinical data and EBM to be translated into
guidelines by scientific societies and countries are needed to better
guide clinicians in the complex management of a diabetes patient who is
COVID-19 positive.